MedPath

BERIPLEX P/N 500

BERIPLEX P/N 500

Approved
DIN Number

02359251

Drug Class

Human

Market Date

Jul 28, 2011

Company
HC

csl behring canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02359251
AIG Number0652205002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD01 COAGULATION FACTOR IX, II, VII AND X IN COMB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification

ACTIVE INGREDIENTS (6)

COAGULATION FACTOR II (HUMAN)Active
Strength: 800 UNIT
Monograph: COAGULATION FACTOR II (HUMAN)
COAGULATION FACTOR IX (HUMAN)Active
Strength: 620 UNIT
Monograph: COAGULATION FACTOR IX (HUMAN)
COAGULATION FACTOR VII (HUMAN)Active
Strength: 500 UNIT
Monograph: COAGULATION FACTOR VII (HUMAN)
COAGULATION FACTOR X (HUMAN)Active
Strength: 1020 UNIT
Monograph: COAGULATION FACTOR X (HUMAN)
PROTEIN CActive
Strength: 820 UNIT
Monograph: PROTEIN C
PROTEIN SActive
Strength: 680 UNIT
Monograph: PROTEIN S

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.